bioRxivBioinformaticsPreprint
Target variant detection in leukemia using unaligned RNA-Seq reads
Eric Olivier AudemardiD, Patrick GendroniD, Vincent‐Philippe LavalléeiD, Josée HébertiD, Guy SauvageauiD, Sébastien LemieuxiD
Abstract
Mutations identified in each Acute Myeloid Leukemia (AML) patients are useful for prognosis and to select targeted therapies. Detection of such mutations by the analysis of Next-Generation Sequencing (NGS) data requires a computationally intensive read mapping step and application of several variant calling methods. Targeted mutation identification drastically shifts the usual tradeoff between accuracy and performance by concentrating all computations over a small portion of sequence space. Here, we present km, an efficient approach leveraging k-mer decomposition of reads to identify targeted mutations. Our approach is versatile, as it can detect single-base mutations, several types of insertions and deletions, as well as fusions. We used two independent AML cohorts (The Cancer Genome Atlas and Leucegene), to show that mutation detection by km is fast, accurate and mainly limited by sequencing depth. Therefore, km allows to establish fast diagnostics from NGS data, and could be suitable for clinical applications.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A k-mer based transcriptomics analysis for NPM1-mutated AML
Raíssa Silva, Cédric Riedel, … Thérèse Commes·medRxiv·Jan 31, 2023
- Comparing machine learning models for predicting mutation status in Acute Myeloid Leukemia patients using RNA-seq data
Raíssa Silva, Cédric Riedel, … Thérèse Commes·bioRxiv·Nov 13, 2024
- Performances of targeted RNA-sequencing for the analysis of fusion transcripts, gene mutation and expression in haematological malignancies.
Sandrine Hayette, Béatrice Grange, … Pierre Sujobert·bioRxiv·Sep 7, 2020
- Unique K-mer sequences for validating cancer-related substitution, insertion and deletion mutations
HoJoon Lee, Ahmed Shuaibi, … Hanlee P. Ji·NAR CancerPeer-reviewed·Dec 1, 2020
- FERMI: A novel method for sensitive detection of rare mutations in somatic tissue
L. Alexander Liggett, Anchal Sharma, … James V. DeGregori·G3 Genes Genomes GeneticsPeer-reviewed·Jul 27, 2019
- Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms
S. H. Rosenthal, A. Gerasimova, … F. Lacbawan·bioRxiv·Nov 30, 2020